title: Unconvincing Benefit of Combination Therapy With Gefitinib and Pemetrexed in Advanced Non-Small-Cell Lung Cancer.
authors.affiliation: Akiko Ota, Bishal Gyawali, Ayumu Matsuoka, and Yuichi Ando, Nagoya University Hospital, Nagoya, Japan.
authors.forename: Akiko
authors.initials: A
authors.lastname: Ota
authors.affiliation: Akiko Ota, Bishal Gyawali, Ayumu Matsuoka, and Yuichi Ando, Nagoya University Hospital, Nagoya, Japan.
authors.forename: Bishal
authors.initials: B
authors.lastname: Gyawali
authors.affiliation: Akiko Ota, Bishal Gyawali, Ayumu Matsuoka, and Yuichi Ando, Nagoya University Hospital, Nagoya, Japan.
authors.forename: Ayumu
authors.initials: A
authors.lastname: Matsuoka
authors.affiliation: Akiko Ota, Bishal Gyawali, Ayumu Matsuoka, and Yuichi Ando, Nagoya University Hospital, Nagoya, Japan.
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Ando
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung; D066246:ErbB Receptors / Q000235:genetics; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms; D009154:Mutation; D000068437:Pemetrexed
chemical_list: D000068437:Pemetrexed; D066246:ErbB Receptors; D000077156:Gefitinib